44,450 Shares in iShares Biotechnology ETF $IBB Acquired by Pictet Asset Management Holding SA
by Doug Wharley · The Cerbat GemPictet Asset Management Holding SA acquired a new position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 44,450 shares of the financial services provider’s stock, valued at approximately $7,590,000. Pictet Asset Management Holding SA owned about 0.09% of iShares Biotechnology ETF as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in the company. Verdence Capital Advisors LLC purchased a new position in iShares Biotechnology ETF in the 4th quarter worth approximately $286,000. Matisse Capital purchased a new position in iShares Biotechnology ETF in the 4th quarter worth approximately $221,000. Sanctuary Advisors LLC raised its holdings in iShares Biotechnology ETF by 58.1% in the 4th quarter. Sanctuary Advisors LLC now owns 39,769 shares of the financial services provider’s stock worth $6,712,000 after acquiring an additional 14,619 shares during the last quarter. Sava Infond d.o.o. purchased a new position in iShares Biotechnology ETF in the 4th quarter worth approximately $253,000. Finally, Concurrent Investment Advisors LLC raised its holdings in iShares Biotechnology ETF by 809.7% in the 4th quarter. Concurrent Investment Advisors LLC now owns 35,689 shares of the financial services provider’s stock worth $6,023,000 after acquiring an additional 31,766 shares during the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.
iShares Biotechnology ETF Stock Performance
Shares of NASDAQ IBB opened at $167.27 on Friday. iShares Biotechnology ETF has a twelve month low of $116.25 and a twelve month high of $179.64. The company has a 50 day moving average of $169.84 and a 200 day moving average of $168.53.
iShares Biotechnology ETF Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were paid a dividend of $0.1218 per share. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%.
About iShares Biotechnology ETF
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.